Forschergruppe Diabetes

Munich

0 studies enrolling now · 1 studies all time

What they study most

Autoantibody Positive, High Risk, Impaired Glucose Tolerance, Non-diabetic Relatives at Risk for Type 1 Diabetes

Studies at this site

• Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" — Completed